Impact of the Omics-Based Biomarkers on the Mirtazapine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder

INTRODUCTION: Mirtazapine is commonly administered to patients with recurrent depressive disorder. Some of these patients do not show adequate response to the therapy with mirtazapine, whereas many of them experience dose-dependent adverse drug reactions. Previous research revealed that CYP2D6 is in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychopharmacol Bull
Main Authors: Zastrozhin, MS, Skryabin, VYu, Smirnov, VYu, Zastrozhina, AK, Kaverina, EV, Klepikov, DA, Grishina, EA, Ryzhikova, KA, Bure, IV, Bryun, EA, Sychev, DA
Formato: Artigo
Idioma:Inglês
Publicado em: MedWorks Media Global 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8146558/
https://ncbi.nlm.nih.gov/pubmed/34092821
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados